UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis

Clinical rheumatology, 2021-09, Vol.40 (9), p.3605-3613

2021

Volltextzugriff (PDF)

Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial)

PloS one, 2023-05, Vol.18 (5), p.e0285725-e0285725

2023

Volltextzugriff (PDF)

Psychiatric Co-Morbidities and Profile of Patients with Irritable Bowel Syndrome in Northern India

Brain sciences, 2024-04, Vol.14 (4), p.393

2024

Volltextzugriff (PDF)

Transhepatic intraperitoneally migrated biliary stent: A rare finding during laparoscopic cholecystectomy

Journal of minimal access surgery, 2021-01, Vol.17 (1), p.85-87

2021

Volltextzugriff (PDF)

APRI and FIB-4 performance to assess liver fibrosis against predefined Fibroscan values in chronic hepatitis C virus infection

Journal of family medicine and primary care, 2021-11, Vol.10 (11), p.4082-4088

2021

Volltextzugriff (PDF)

Non-invasive predictors to grade esophageal varices in liver cirrhosis patients

Journal of family medicine and primary care, 2024-04, Vol.13 (4), p.1232-1237

2024

Volltextzugriff (PDF)

Coronavirus Disease (COVID-19) Outbreak and Adaptive Immune System of the Body: A Review

Journal of clinical and diagnostic research, 2020-10, Vol.14 (10), p.DE06-DE11

2020

Volltextzugriff (PDF)

Comparison of Haematological Variables in Helicobacter Pylori-Infected Patients with Ulcer and without Ulcer: A Cross-sectional Study

Journal of clinical and diagnostic research, 2023-08, Vol.17 (8), p.09-13

2023

Volltextzugriff (PDF)

Malnutrition in Liver Cirrhosis: A Review

Journal of clinical and diagnostic research, 2019-05, Vol.13 (5), p.OE01-OE05

2019

Volltextzugriff (PDF)

Thyroid functions and serum lipid profile in metabolic syndrome

Biomedical Journal, 2017-06, Vol.40 (3), p.147-153

2017

Volltextzugriff (PDF)

Novel coronavirus (COVID-19) and its potential G.I. manifestation: A review

Journal of family medicine and primary care, 2020-11, Vol.9 (11), p.5474-5479

2020

Volltextzugriff (PDF)

Letter to the editor: Nanoparticle therapeutic vaccine for hepatitis B: An unfulfilled dream

Hepatology (Baltimore, Md.), 2022-08, Vol.76 (2), p.E29-E29

2022

Volltextzugriff (PDF)

Management of HAPE with bed rest and supplemental oxygen in hospital setting at high altitude (11,500 ft): A review of 43 cases

Journal of Association of Chest Physicians, 2017-01, Vol.5 (1), p.31-34

2017

Volltextzugriff (PDF)

A rare cause of ascites

Journal of clinical and experimental hepatology, 2024, Vol.14, p.102329, Article 102329

2024

Volltextzugriff (PDF)

Comparison of various prognostic scores in ethanol-related acute-on-chronic liver failure- prospective study

Journal of clinical and experimental hepatology, 2024, Vol.14, p.102096, Article 102096

2024

Volltextzugriff (PDF)

FRI-269 - Serum metabolite revel mirochondrial dysfunction and energy metablism disruption in chronic hepatitis C virus infection

Journal of hepatology, 2023-06, Vol.78, p.S1050-S1050

2023

Volltextzugriff (PDF)

Serum metabolite revel mirochondrial dysfunction and energy metablism disruption in chronic hepatitis C virus infection

Journal of hepatology, 2023-06, Vol.78, p.S1050

2023

Volltextzugriff (PDF)

Comparison of liver stiffness, splenic stiffness and novel hepato-splenic stiffness gradient ratio as a non-invasive predictor of varices in patients with compensated advanced chronic liver disease

Journal of clinical and experimental hepatology, 2024, Vol.14, p.102055, Article 102055

2024

Volltextzugriff (PDF)

The metabolic fingerprint of chronic hepatitis C progression: Metabolome shifts and cutting‐edge diagnostic options

Journal of molecular recognition, 2024-01, Vol.37 (1), p.e3066-n/a

2024

Volltextzugriff (PDF)

Acute hepatitis C treatment in advanced renal failure using 8 weeks of pan-genotypic daclatasvir and reduced-dose sofosbuvir

Nephrology, dialysis, transplantation, 2021-09, Vol.36 (10), p.1867-1871

2021

Volltextzugriff (PDF)

Serum Prolidase Activity, Oxidant and Antioxidant Status in Nonulcer Dyspepsia and Healthy Volunteers

ISRN biochemistry, 2013-10, Vol.2013, p.182601-6

2013

Volltextzugriff (PDF)

Spontaneous pneumothorax: an unusual complication of pregnancy--a case report and review of literature

Annals of thoracic medicine, 2008-07, Vol.3 (3), p.104-105

2008

Volltextzugriff (PDF)

Viral Suppression is Comparable with 0.5 mg and 1.0 mg Daily doses of Entecavir in Treatment-Naive HBV-Related Decompensated Cirrhosis

Antiviral therapy, 2020-01, Vol.25 (5), p.267-273

2020

Volltextzugriff (PDF)

Risk factors of advanced fibrosis and cirrhosis in patients with chronic hepatitis C in India

Journal of clinical and experimental hepatology, 2024, Vol.14, p.102310, Article 102310

2024

Volltextzugriff (PDF)

Profile of patients who failed to achieve sustained virological response with sofosbuvir containing first line antiviral therapy in India

Journal of clinical and experimental hepatology, 2024, Vol.14, p.102305, Article 102305

2024

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(38)
Berichte
(2)

Sprache

Englisch
(40)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis

Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial)

Psychiatric Co-Morbidities and Profile of Patients with Irritable Bowel Syndrome in Northern India

Transhepatic intraperitoneally migrated biliary stent: A rare finding during laparoscopic cholecystectomy

APRI and FIB-4 performance to assess liver fibrosis against predefined Fibroscan values in chronic hepatitis C virus infection

Non-invasive predictors to grade esophageal varices in liver cirrhosis patients

Coronavirus Disease (COVID-19) Outbreak and Adaptive Immune System of the Body: A Review

Comparison of Haematological Variables in Helicobacter Pylori-Infected Patients with Ulcer and without Ulcer: A Cross-sectional Study

Malnutrition in Liver Cirrhosis: A Review

Thyroid functions and serum lipid profile in metabolic syndrome

Novel coronavirus (COVID-19) and its potential G.I. manifestation: A review

Letter to the editor: Nanoparticle therapeutic vaccine for hepatitis B: An unfulfilled dream

Management of HAPE with bed rest and supplemental oxygen in hospital setting at high altitude (11,500 ft): A review of 43 cases

A rare cause of ascites

Comparison of various prognostic scores in ethanol-related acute-on-chronic liver failure- prospective study

FRI-269 - Serum metabolite revel mirochondrial dysfunction and energy metablism disruption in chronic hepatitis C virus infection

Serum metabolite revel mirochondrial dysfunction and energy metablism disruption in chronic hepatitis C virus infection

Comparison of liver stiffness, splenic stiffness and novel hepato-splenic stiffness gradient ratio as a non-invasive predictor of varices in patients with compensated advanced chronic liver disease

The metabolic fingerprint of chronic hepatitis C progression: Metabolome shifts and cutting‐edge diagnostic options

Acute hepatitis C treatment in advanced renal failure using 8 weeks of pan-genotypic daclatasvir and reduced-dose sofosbuvir

Serum Prolidase Activity, Oxidant and Antioxidant Status in Nonulcer Dyspepsia and Healthy Volunteers

Spontaneous pneumothorax: an unusual complication of pregnancy--a case report and review of literature

Viral Suppression is Comparable with 0.5 mg and 1.0 mg Daily doses of Entecavir in Treatment-Naive HBV-Related Decompensated Cirrhosis

Risk factors of advanced fibrosis and cirrhosis in patients with chronic hepatitis C in India

Profile of patients who failed to achieve sustained virological response with sofosbuvir containing first line antiviral therapy in India

Suchergebnisse filtern